Literature DB >> 8666991

New species of human tyrosine hydroxylase mRNA are produced in variable amounts in adrenal medulla and are overexpressed in progressive supranuclear palsy.

S Dumas1, H Le Hir, S Bodeau-Péan, E Hirsch, C Thermes, J Mallet.   

Abstract

Alternative splicing of human tyrosine hydroxylase (TH) pre-mRNA produces four mRNAs leading to four different TH isoforms and is thought to have important regulatory functions. We show that the diversity of TH mRNAs is greater than previously described in the autonomous nervous system: New splice junctions corresponding to the skipping of exon 3 were identified by amplification of cDNA synthesized from pheochromocytoma RNA. In all cases the reading frame was maintained. These species were assayed by RNase protection experiments; their abundance (4-6%) was comparable to that of the previously identified human TH-3 and -4 species in normal adrenal medulla. However, higher levels (11-34%) of these species were found in adrenal medullas of patients suffering from progressive supranuclear palsy. Whether such changes are specific to the disease or the consequences of the stress associated with this severe neurodegeneration remains to be established.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666991     DOI: 10.1046/j.1471-4159.1996.67010019.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

2.  A quantitative analysis of intron effects on mammalian gene expression.

Authors:  Ajit Nott; Shlomo H Meislin; Melissa J Moore
Journal:  RNA       Date:  2003-05       Impact factor: 4.942

Review 3.  A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC).

Authors:  R A Wevers; J F de Rijk-van Andel; C Bräutigam; B Geurtz; L P van den Heuvel; G C Steenbergen-Spanjers; J A Smeitink; G F Hoffmann; F J Gabreëls
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 4.  A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

Authors:  Shams Tabrez; Nasimudeen R Jabir; Shazi Shakil; Nigel H Greig; Qamre Alam; Adel M Abuzenadah; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

Review 5.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

Review 6.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors:  Toshiharu Nagatsu; Ikuko Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-04       Impact factor: 3.575

7.  Premature termination codons do not affect the rate of splicing of neighboring introns.

Authors:  J Robin Lytle; Joan A Steitz
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

Review 8.  Human tyrosine hydroxylase in Parkinson's disease and in related disorders.

Authors:  Toshiharu Nagatsu; Akira Nakashima; Hiroshi Ichinose; Kazuto Kobayashi
Journal:  J Neural Transm (Vienna)       Date:  2018-07-11       Impact factor: 3.575

Review 9.  The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes.

Authors:  Toshiharu Nagatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2007-01-12       Impact factor: 3.493

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.